Writing in the Global Health Technologies Coalition’s (GHTC) “Breakthroughs” blog, GHTC Communications Officer Kim Lufkin summarizes the group’s annual congressional briefing, “which focused on how U.S. policymakers can protect the nation’s investments in global health research in upcoming budget discussions.” She writes, “As the panelists stressed, there are several compelling humanitarian reasons to protect U.S. investments in global health research,” and adds the speakers “also emphasized that there are countless domestic benefits that come with U.S. investments in global health research.” Lufkin includes comments from the panelists, who included Alan Magill, director of malaria at the Bill & Melinda Gates Foundation; Lisa Cohen, executive director of the Washington Global Health Alliance; and Caroline Ryan, deputy coordinator for Technical Leadership at PEPFAR (2/28).